Kintor Pharmaceutical (HKSE:09939) Price-to-Tangible-Book : 1.88 (As of May. 25, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Kintor Pharmaceutical Price-to-Tangible-Book?

As of today (2024-05-25), Kintor Pharmaceutical's share price is HK$1.28. Kintor Pharmaceutical's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was HK$0.68. Hence, Kintor Pharmaceutical's Price to Tangible Book Ratio of today is 1.88.

The historical rank and industry rank for Kintor Pharmaceutical's Price-to-Tangible-Book or its related term are showing as below:

HKSE:09939' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.78 Med: 2.67 Max: 3.22
Current: 1.88

During the past 6 years, Kintor Pharmaceutical's highest Price to Tangible Book Ratio was 3.22. The lowest was 1.78. And the median was 2.67.

HKSE:09939's Price-to-Tangible-Book is ranked better than
66.67% of 1221 companies
in the Biotechnology industry
Industry Median: 2.79 vs HKSE:09939: 1.88

A closely related ratio is called PB Ratio. As of today, Kintor Pharmaceutical's share price is HK$1.28. Kintor Pharmaceutical's Book Value per Sharefor the quarter that ended in Dec. 2023 was HK$1.12. Hence, Kintor Pharmaceutical's P/B Ratio of today is 1.14.

Kintor Pharmaceutical Price-to-Tangible-Book Historical Data

The historical data trend for Kintor Pharmaceutical's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kintor Pharmaceutical Price-to-Tangible-Book Chart

Kintor Pharmaceutical Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

2.53

2.81

3.22

2.40

Kintor Pharmaceutical Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial						2.81	6.50	3.22	1.35	2.40

Competitive Comparison of Kintor Pharmaceutical's Price-to-Tangible-Book

For the Biotechnology subindustry, Kintor Pharmaceutical's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kintor Pharmaceutical's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kintor Pharmaceutical's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Kintor Pharmaceutical's Price-to-Tangible-Book falls into.

Kintor Pharmaceutical Price-to-Tangible-Book Calculation

Kintor Pharmaceutical's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	1.28	/	0.68
	=	1.88

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Kintor Pharmaceutical Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Kintor Pharmaceutical's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Kintor Pharmaceutical (HKSE:09939) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kintor Pharmaceutical Ltd (HKSE:09939) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

KNTPF:USA

Address

No. 20 Songbei Road, Suzhou Industrial Park, Jiangsu, Suzhou, CHN, 215123

Website

https://www.kintor.com.cn

Kintor Pharmaceutical Ltd is a clinical-stage novel drug developer in China focused on the proprietary R&D of drugs for cancers and other AR-related diseases. The company's drug candidate, Pruxelutamide, is a drug undergoing phase III clinical trials in China and phase III clinical trials in the United States for mCRPC as well as clinical trials for breast cancer. Its pipeline of seven drug candidates includes Pruxelutamide (GT0918), Pyrilutamide (KX-826), ALK-1 (GT90001), Detorsertib (GT0486), Hedgehog/SMO Inhibitor (GT1708F), PD-L1/TGF-ß (GT90008), and AR-PROTAC Compound (GT20029). It operates in a single segment focusing on the research and development of medical products.

Executives

Tong Youzhi	2101 Beneficial owner
Kt International Investment Limited	2101 Beneficial owner
Guo Chuangxing	2201 Interest of corporation controlled by you
Kg Development Limited	2101 Beneficial owner
Nomura Holdings, Inc.	2201 Interest of corporation controlled by you
Tong Youzhi	2201 Interest of corporation controlled by you
Zhu Hai Ge Li Jin Rong Tou Zi Guan Li You Xian Gong Si	2101 Beneficial owner
Zhu Hai Ge Li Ji Tuan You Xian Gong Si	2201 Interest of corporation controlled by you
Sovereign Fiduciaries (hong Kong) Limited
Kiya Company Limited
Lian Xiang Kong Gu Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you
Nan Ming You Xian Gong Si	2201 Interest of corporation controlled by you
Shi Xian You Xian Gong Si	2101 Beneficial owner

Kintor Pharmaceutical (HKSE:09939) Headlines

No Headlines